Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 April 2023 | Story Gerda-Marié van Rooyen | Photo Two Oceans Marathon Twitter
Gerda Steyn  winning the 2023 Two Oceans Marathon
Former UFS student, Gerda Steyn, made history this weekend – she is the first woman to win the Two Oceans Ultra Marathon four consecutive times.

Kovsie alumna Gerda Steyn provided much jubilation on Saturday 15 April 2023, as she became the first woman to win the Two Oceans Marathon four consecutive times. Steyn, who represented South Africa in the 2020 Summer Olympics held in Tokyo, Japan, in 2021, improved her personal best by finishing the race 39 seconds faster than her winning time in 2022.

Shortly after her fourth win in the 56 km race, Steyn told media that the desire to inspire girls kept her motivated during the race. “I thought of all the girls watching (the race) with their parents and seeing a woman who looked like everyone else winning this big race.” The former University of the Free State (UFS) professional athlete managed an average pace of 3:45 minutes per kilometre. Steyn proved that hard work pays off, as she finished 14th at the Two Oceans Ultra Marathon in 2016. Her first-ever first place at this race was in 2018, and again in 2019 and 2022 – the marathon was cancelled in 2020 and 2021 due to the COVID-19 pandemic.

Proving that she not only has golden feet but a heart of gold too, she pledged to donate some of her bonus money towards the development of athletes living in Muizenberg shortly after she won the Two Oceans in record time in 2022. A true example of perseverance and hard work, she also won the Comrades Marathon in 2019, and finished seventh in the London Marathon in 2020. 

Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, says that Gerda is an embodiment of focus and determination. “I am so proud of her. The UFS is truly the home of champions, as can be seen by the achievements of Olympic track athletes Wayde van Niekerk, Louzanne Coetzee, and champions in many other sporting codes.”

Saturday’s Two Oceans Marathon saw Ethiopian-born Amelework Fikadu Bosho finish second in the women’s race – crossing the finish line 12 minutes after Steyn – with Carla Molinaro from Britain in the third position. Approximately 10 000 athletes entered the race, starting at the Newlands Stadium and ending on the University of Cape Town's campus.

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept